Impacts of glucagon‐like peptide‐1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction‐associated steatotic liver disease cirrhosis and type 2 diabetes

Elsaid, Mohamed I., Li, Na, Firkins, Stephen A. · Alimentary Pharmacology & Therapeutics · 2024